One Global Service Provider FY26 Profit Jumps to Rs 69.50 Crore

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
One Global Service Provider FY26 Profit Jumps to Rs 69.50 Crore

One Global Service Provider reported a stellar FY26 with revenue hitting Rs 498.81 crore and PAT rising to Rs 69.50 crore. Shareholders at the 34th AGM approved a strategic acquisition of a 51% stake in Matrix Labs entities to bolster its healthcare diagnostic ecosystem.

One Global Service Provider FY26 Revenue Hits Rs 498.81 Crore

Profit After Tax Climbs to Rs 69.50 Crore

Reader Takeaway: Robust financial growth driven by healthcare expansion; investors should track integration of recent diagnostic firm acquisitions.

What just happened

One Global Service Provider Limited held its 34th Annual General Meeting on September 29, 2026, outlining a strong financial year. The company reported a significant jump in revenue to Rs 498.81 crore, up from Rs 147.84 crore in the previous year. Profit after tax saw a sharp increase to Rs 69.50 crore, compared to Rs 18.47 crore in FY25. The company’s Return on Equity also improved significantly, reaching 49.21%.

Why this matters

The company is aggressively pivoting toward an integrated healthcare ecosystem. The successful amalgamation of Plus Care Internationals is complete, and shareholders have now approved a 51% equity stake acquisition in both Matrix Labs Diagnocare Private Limited and Matrix Labs Private Limited. To fund this, the company gained approval for a preferential issuance of 706,068 equity shares.

Governance and Operations

During the meeting, shareholders approved the reappointment of Mr. Sanjay Lalbhadur Upadhaya as Managing Director. M/s. SDPM & Co. were appointed as statutory auditors for a five-year term. The company also secured approval to adjust its authorized share capital and set new borrowing limits to support its expansion into AI-driven healthcare solutions, laboratory reagents, and hospital management software.

What to track next

Investors should monitor the official filing of the final voting results from the AGM and the actual timeline for the preferential share allotment. The integration of the Matrix Labs entities will be the next major operational milestone to gauge the company's capability to scale its diagnostic service footprint.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.